| Product Code: ETC11635587 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Mauritius saw a diverse range of countries exporting cholesterol lowering agents, with India, Metropolitan France, Germany, Turkey, and the UK leading the pack. The market showed a shift from high to moderate concentration, indicating a more balanced distribution among suppliers. The CAGR of 4.71 from 2020 to 2024 reflects steady growth, although there was a slight decline in the growth rate from 2023 to 2024. This dynamic landscape suggests a maturing market with opportunities for both local and international players to capitalize on the demand for cholesterol-lowering agents in Mauritius.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Cholesterol Lowering Agents Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Cholesterol Lowering Agents Market - Industry Life Cycle |
3.4 Mauritius Cholesterol Lowering Agents Market - Porter's Five Forces |
3.5 Mauritius Cholesterol Lowering Agents Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Mauritius Cholesterol Lowering Agents Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Mauritius Cholesterol Lowering Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mauritius Cholesterol Lowering Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Cholesterol Lowering Agents Market Trends |
6 Mauritius Cholesterol Lowering Agents Market, By Types |
6.1 Mauritius Cholesterol Lowering Agents Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By Statins, 2021 - 2031F |
6.1.4 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By Bile Acid Sequestrants, 2021 - 2031F |
6.1.5 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By Nicotinic Acid, 2021 - 2031F |
6.1.6 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By PCSK9 Inhibitors, 2021 - 2031F |
6.1.7 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Mauritius Cholesterol Lowering Agents Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By Hypercholesterolemia, 2021 - 2031F |
6.2.3 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.4 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By Hyperlipidemia, 2021 - 2031F |
6.3 Mauritius Cholesterol Lowering Agents Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Mauritius Cholesterol Lowering Agents Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Mauritius Cholesterol Lowering Agents Market Import-Export Trade Statistics |
7.1 Mauritius Cholesterol Lowering Agents Market Export to Major Countries |
7.2 Mauritius Cholesterol Lowering Agents Market Imports from Major Countries |
8 Mauritius Cholesterol Lowering Agents Market Key Performance Indicators |
9 Mauritius Cholesterol Lowering Agents Market - Opportunity Assessment |
9.1 Mauritius Cholesterol Lowering Agents Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Mauritius Cholesterol Lowering Agents Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Mauritius Cholesterol Lowering Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mauritius Cholesterol Lowering Agents Market - Competitive Landscape |
10.1 Mauritius Cholesterol Lowering Agents Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Cholesterol Lowering Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here